The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof. Compounds of formula I are inhibitors of Janus kinases and as such are useful for the treatment of various diseases and conditions mediated by said enzymes, such as rheumatoid arthritis, asthma, COPD, ALS, and the like.
[EN] AZAINDOLES AS JANUS KINASE INHIBITORS<br/>[FR] AZAINDOLES COMME INHIBITEURS DE JANUS KINASE
申请人:MERCK SHARP & DOHME
公开号:WO2011137022A1
公开(公告)日:2011-11-03
The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof. Compounds of formula I are inhibitors of Janus kinases and as such are useful for the treatment of various diseases and conditions mediated by said enzymes, such as rheumatoid arthritis, asthma, COPD, ALS, and the like.